Jennison Associates LLC United Therapeutics Corp Transaction History

Jennison Associates LLC

  • $160 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 09, 2023
BUY
$205.95 - $280.43 $4.46 Million - $6.07 Million
21,645 Added 1035.15%
23,736 $6.6 Million
Q3 2022

Nov 01, 2022
SELL
$203.3 - $244.17 $1.29 Million - $1.55 Million
-6,336 Reduced 75.19%
2,091 $438,000
Q2 2022

Aug 02, 2022
BUY
$174.81 - $241.14 $1.47 Million - $2.03 Million
8,427 New
8,427 $1.99 Million

Others Institutions Holding UTHR

# of Institutions
669
Shares Held
42.8M
Call Options Held
194K
Put Options Held
295K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.7B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Jennison Associates LLC Portfolio

Follow Jennison Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jennison Associates LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email